SUMMARY
Uptake of water from irrigating fluid via open venous sinuses in the prostatic bed results in dilutional hyponatraemia and hypo-osmolality in the transurethral prostatectomy (TURP) syndrome. Hyponatraemia and hypo-osmolality cause CNS disturbances (drowsiness, confusion, convulsions and pontine myelinolysis if severe) [1] . The incidence of this complication is reported to be 2-10% [2, 3] .
Frusemide is a loop diuretic used commonly after prostatectomy to promote diuresis, reducing the risk of clot retention. Mannitol, an osmotic diuretic, causes primarily water excretion by the kidney [4, 5] . This study was undertaken to compare the effects of mannitol and frusemide on sodium and water excretion after transurethral prostatectomy, and their ability to influence the development of the TURP syndrome.
PATIENTS AND METHODS
We studied patients undergoing TURP under spinal anaesthesia. Informed consent was obtained from each patient. A pilot study of 10 patients was undertaken, after which the dose of mannitol was altered, followed by a study of 30 patients receiving either frusemide or mannitol after prostatectomy, and a study of five patients given mannitol during prostatic resection. Diabetic subjects (5 % glucose was used as the carrier for frusemide) and patients unsuitable for spinal anaesthesia were excluded from the study.
All long term medications were given on the morning of surgery. Three patients in the mannitol group and one patient in the frusemide group were receiving long term diuretics, which were given on the morning of surgery. Diazepam 10 mg was given orally 2h before operation; no additional sedation was given during surgery. Hartmann's solution 10 ml kg" 1 was used for i.v. volume loading before spinal anaesthesia, and additional Hartmann's solution was infused during prostatic resection to maintain the systolic arterial pressure > 100 mm Hg; no significant hypotension was encountered during the operation. Spinal anaesthesia was produced with 0.5% bupivacaine 3.5 ml. A 16-gauge i.v. cannula was inserted for blood sampling in the antecubital fossa opposite to the i.v. infusion.
Diuretic therapy
At the end of prostatic resection, patients were allocated randomly to receive an i.v. infusion, over 10 min, of either frusemide or mannitol. The infusions were constituted in identical bottles with coded labels: randomization was by opening a sealed envelope, assigning the code-word of an infusion. Patients and investigators were blinded to the diuretic used.
In the pilot study, frusemide 40 mg (in 200 ml of 5 % glucose) was compared with mannitol 40 g (200 ml of a 20 % solution). In the main study frusemide 40 mg (in 400 ml of 5 % glucose) and mannitol 80 g (400 ml of a 20 % solution) were compared. In all cases the infusions were given over 10 min.
After completion of the diuretic infusion the patients received a standardized i.v. fluid regimen of 0.9 % sodium chloride 80 ml h" 1 for the first 24 h after operation. Patients were encouraged to take oral fluids on the evening of surgery.
Age, body weight, total volume of i.v. fluid infused during operation (from preload before spinal anaesthesia to end of resection), oral intake in the first 12 h after operation, duration of prostatic resection and weight of gland resected were recorded. Urine output was measured every 1 h after operation. Patients were observed for confusion, drowsiness, agitation and changes in arterial pressure.
Blood samples for measurement of sodium concentration and osmolality were taken before operation, at the end of prostatic resection (before diuretic), 1 and 4 h after surgery, and the following morning. Urine samples for measurement of osmolality were taken before operation, 1 and 4 h after surgery, and the following morning. Plasma and urine [Na + ] were measured using flame photometry, and osmolality by depression of freezing point using a Fiske osmometer.
Statistical analysis
Data were subjected to goodness of fit tests to confirm normal distribution. Demographic data were compared using unpaired Student's t tests. Data comparing preoperative and postoperative biochemistry within each group were analysed using paired Student's t tests; differences between groups were compared using unpaired Student's t tests. "V square" (Chi-squared test with correction for sample size) tests were used to compare non-parametric data (incidence of symptoms and complications) [6] . P < 0.05 was taken as significant. Values are expressed as mean (SD).
RESULTS

Pilot study
Ten patients were studied: five received mannitol 40 g and five frusemide 40 mg. The mean urine output in the first 1 h after operation was 186 (123) ml in the mannitol group and 387 (288) ml in the frusemide group. No untoward effects were noted. Because of the lesser urine output, the dose of mannitol was doubled to 80 g for the main study. Unless stated otherwise, all subsequent data refer to the main study.
Main study
Fifteen patients received frusemide 40 mg and 15 received mannitol 80 g, at the end of prostatic resection. There were no differences between the two groups as regards age, weight, duration of prostatic resection, mass of gland resected, volume of i.v. fluid administered during the operation and oral intake after operation (table I) .
Urine volume
Urine output was measured in 11 patients in each group: the other patients required con- tinuous irrigation of the bladder after operation because of bleeding, rendering assessment of urine output impossible. Measured urine output was significantly greater in the first 1 h after operation in patients who received frusemide (P < 0.05); thereafter volumes were similar for each group (table II) .
Urinary excretion of sodium
Urinary excretion of sodium was less in the mannitol group than in the frusemide group at both 1 and 4 h after operation. By the following morning the groups were similar (table II) .
Plasma osmolality
The mannitol group had significantly greater plasma osmolality at 1 and 4 h after operation (table II) . There was an increase in plasma osmolality with administration of mannitol (at 1 h after operation compared with the end of resection (P < 0.05)), whereas administration of frusemide was associated with a decrease in plasma osmolality (at 4 h compared with the end of resection (P < 0.05)). Both groups showed decreases in plasma osmolality by the next morning compared with the end of resection (P < 0.05). The range of plasma osmolality was 269-298 mosmol kg" 1 (normal range 275-295 mosmol kg" 1 ).
Plasma concentration of sodium
Both groups showed decreases in plasma sodium concentration at 1 h, 4 h and the morning following surgery compared with before operation (P < 0.05). On the morning following surgery, the mannitol group had a plasma concentration of sodium significantly greater than that in the frusemide group (table II) . The range of plasma concentration of sodium was 112-143 mmol litre"
1 .
Symptoms and complications
Thirst in the postoperative period was volunteered significantly more frequently in the mannitol group (seven given mannitol, two given frusemide) (P < 0.05).
There was no statistical difference between the groups in the incidence of confusion, drowsiness or agitation (one patient given mannitol, four given frusemide). The mean value for lowest plasma concentration of sodium was 124.8 (10.4) mmol litre" 1 for patients with CNS symptoms, compared with 133.4 (3.5) mmol litre" 1 for those without (P < 0.05).
One patient in the mannitol group and two in the frusemide group received blood transfusions because of bleeding. Increased i.v. fluid was given when clinical evidence suggested hypovolaemia in the immediate postoperative period (hypotension, syncope, cold periphery); this was necessary in two patients who received mannitol compared with seven patients who received frusemide (P < 0.05).
Administration of mannitol during prostatic resection
Mannitol 80 g given during prostatic resection to five patients increased plasma osmolality during surgery (from 284 (6.3) mosmol kg" 1 to 290 (3.8) mosmol kg" 1 ) (P < 0.05), which was similar to the change when mannitol was given after operation.
DISCUSSION
The TURP syndrome varies in severity from drowsiness and confusion, to coma, convulsions and pontine myelinolysis [3] . Diuretic therapy is intended primarily to prevent bladder clot retention after TURP, but may aggravate or ameliorate the TURP syndrome.
Both mannitol 80 g and frusemide 40 mg were effective in promoting diuresis after prostatectomy. Urine output in the first 1 h was less (but "adequate") with mannitol and could be overcome by administration during surgery.
Frusemide induces a sodium diuresis, in contrast with the relatively sodium-sparing osmotic diuretic, mannitol [4, 5] . Sodium depletion consequent on the natriuresis may precipitate hypovolaemia. Mannitol 20% is a hypertonic solution and would be expected to increase extracellular volume [7] . Previous studies have documented a transient expansion in blood volume, returning to normal after 30 min [8] . This contrasts with the tendency to hypovolaemia with frusemide and is consistent with the greater incidence of clinically suspected hypovolaemia seen with frusemide in the immediate postoperative period of this study. However, caution is needed in interpreting these findings, as blood loss was not quantified and decisions to transfuse blood or increase i.v. fluids were made only on clinical grounds.
This study confined itself to the water intoxication component of the TURP syndrome as identified by its biochemical hallmarks: hyponatraemia and hypo-osmolality. In a study of this size, significant differences in the incidence of clinical CNS disturbances would be unlikely. However, the results suggest that mannitol might reduce the incidence of CNS disturbances after TURP. CNS disturbances may also follow glycine intoxication, which can occur independently of the degree of water intoxication [9] .
The small changes in mean plasma sodium concentration for the groups as a whole (138.5 to 132.9 mmol litre" 1 with frusemide) hide the magnitude of changes in individual subjects. For example, two patients receiving frusemide had reductions in plasma concentration of sodium from 140 and 136 mmol litre" 1 to 115 and 112 mmol litre" 1 , respectively, with associated CNS changes. As sodium chloride is the principal solute of the extracellular space, hyponatraemia is usually indicative of hypo-osmolality; in pure water intoxication this is reliable, but not if an extra solute is present. In the presence of high concentrations of mannitol, extreme hyponatraemia ([Na + ] 99 mmol litre" 1 ) with normal plasma osmolality has been reported, with no CNS effects of water intoxication [10] . We suggest that hypo-osmolality is a more appropriate marker of water intoxication than hyponatraemia.
Mannitol has an established role in treating water intoxication by drawing water from the intracellular space, reducing brain oedema, and increasing urinary water loss [11] . A slow infusion of mannitol during surgery is preferable to prevent hypo-osmolality. Central pontine myelinolysis has been linked to rapid correction of hypo-osmolality [1, 12] . Likewise, commencing the diuresis during the operation should also ensure adequate urine flow during the first minutes after operation-the most crucial time in the prevention of clot retention.
